Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Clinical studies have demonstrated that in immunotherapy resistant melanoma patients, combining FMT with immune checkpoint inhibition therapy significantly increases CD8 T cells, CD4 T cells, and activated DCs within the TME, and upregulates Th1 cytokines such as IFN- and IL-12, thereby improving the bodys response rate to PD-1/CTLA-4 inhibitors [231, 232]
10.1016/j.canlet.2018.04.021 139 WardM
The authors express gratitude for the technical guidance provided by HMU computer center sincerely
Presented for research literature review only Kelly GS (1998)
US$ 22.07
US$ 29.50
US$ 28.99
US$ 28.36
US$ 23.68
